TAG:
cap
Pathology Competitors Make Florida The Target
CEO SUMMARY: Florida is about to become the marketing battleground for anatomic pathology. Three well-funded players are preparing to launch major sales efforts. Pathologists in the state wait with trepidation. Expectations of discounted pricing and a “gloves-off” sales strategy conce…
Kaiser Reports Huge Loss, Many HMOs Losing Money
CEO SUMMARY: Poor financial performance of many managed care plans is bad news for clinical laboratories. Those insurance plans losing money find it tough to increase reimbursement for laboratory tests. Financial struggles of the health insurance industry should be closely watched for its…
Catholic Healthcare West, Tenet Form Joint Venture
CEO SUMMARY: This consolidation initiative brings together the resources of both hospital operators. The objective of the partnership is to more efficiently align services in California’s San Joaquin Valley. This is a proactive step that anticipates further reductions in reimbursement a…
AmeriPath, SmithKline, Unilab, IMPATH, LabOne, Prudential/SBCL
AMERIPATH REPORTS EARNINGS, NEW PURCHASE AmeriPath, Inc. of Riviera Beach, Florida announced its 1997 financial performance. For the year, company revenues totaled $108.4 million. On February 17, the company also disclosed the acquisition of Anatomic Pathology Associates (A…
Automated Pap Screening Gains Recommendation
CEO SUMMARY: Automated cytology technology received a big boost when the FDA’s advisory panel voted to recommend that the FDA approve, with conditions, NeoPath’s AutoPap® System as a primary Pap Smear Screener. The company still awaits final FDA approval on this matter….
Neuromedical’s PAPNET® Undergoing Enhancement
CEO SUMMARY: Financial pressures and a falling stock price impelled Neuromedical Systems, Inc. to revamp its sales and marketing plan for the PAPNET® System. During 1998, expect a new sales approach that supports a product with enhanced capabilities. Neuromedical is developing overseas m…
Automated Cytology Technology To Come Into Its Own In 1998
CEO SUMMAR…
SmithKline May Merge With Glaxo Wellcome
CEO SUMMARY: Both companies confirm that merger talks are under way. The merger is another example of consolidation within the healthcare industry, and is expected to trigger mergers between other drug companies. Fate of SmithKline’s clinical laboratory division in the merger with Glaxo…
Small is Beautiful
I MAY BE THE FIRST TO PUBLICLY DESCRIBE an emerging market trend in the laboratory industry. Starting in the mid-1980s, small laboratories disappeared from the landscape at an astonishing rate. Within the commercial laboratory segment, acquisitions of small laboratories fueled the consolidation proce…
30-Hospital Lab Contract Inked By Tenet & SBCL
CEO SUMMARY: By signing this deal with Tenet, SmithKline Beecham Clinical Laboratories captured one of the largest hospital laboratory management contracts ever offered. The project’s size, scale and far-flung geography make this a daunting challenge, particularly given California’s c…
CURRENT ISSUE
Volume XXXIII, No. 4 – March 23, 2026
A federal court ruling has established a safe harbor for clinical labs when they run tests ordered by physicians. Lab leaders should examine this briefing for pitfalls. Also, it turns out that providers may be ordering inappropriate vitamin D tests, according to one expert.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.